A study looking at pertuzumab for HER2 positive breast cancer that has spread (PERUSE)

Overview

Cancer types:

Breast cancer, Secondary cancers

Status:

Results

Phase:

Phase 3

Details

This study looked at pertuzumab (Perjeta) and trastuzumab (Herceptin) with a taxane chemotherapy drug. It was for people with breast cancer that was HER2 positive.

This study was open to women and men whose breast cancer had spread into surrounding tissue (locally advanced breast cancer). And to those whose cancer had spread to another part of their body (secondary breast cancer).

This study was open for people to join between 2012 and 2014. The team published the results in 2020.

Recruitment start: 31 May 2012

Recruitment end: 19 February 2014